Expert Providers of Cancer Patient Samples
Detecting and diagnosing cancer earlier is a key aspect in decreasing cancer-related mortality. An estimated 15% of cancer-related deaths could be prevented if they were diagnosed at stage III rather than stage IV, highlighting the need for improved cancer diagnostic tests. We specialise in providing cancer serum and plasma specimens and understand the importance of annotated biological samples for your research.
Clinical Specimens
Pretreatment Specimens
Matched Sets
Prospective Collections
Disease staged cancer serum or plasma
We offer a wide selection of markers including CA125, CA15-3, CA72-4, Cyfra21-1 and SCLC, and our samples are accompanied by detailed documentation and ethically collected.
- Pre-treatment donor samples
- Confirmed diagnosis
- Test method and analyte concentration provided
- Bulks available for some markers
Prospective Collection Project Examples
Pre-treatment, Diseased Staged Cancer Serum
Marker: Small Cell Lung Carcinoma (SCLC)
Number of lots: 120 donors
Matrix: Serum
Volume per lot:5 x 1ml aliquots from each donor
Specification: Pre-treatment donors, no freeze-thaw cycles
Donor information: SCLC Disease-stage recorded, age, gender, date of collection, ethnicity
Cyfra-21-1 Remnant samples collection
Markers: Cyfra 21-1
Number of lots: 300 donors
Matrix: Serum
Test Performed: Fujirebio CanAg Cyfra 21-1 EIA (ng/mL)
Volume per lot:0.5 ml from each donor
Specification: Variable titres ranging 4-90 ng/mL
Donor information: Date of collection, titre
Search Our Products
Related Blogs
)